This paper is an attempt to enrich the literature about the role that can play some economic approaches, such as cost-effectiveness analysis, in order to help medical stuffs to decide about the treatment to adopt in case of a chronic disease such as Haemophilia. Data from morocco were gathered in order to explain the importance of such approaches
Musculoskeletal impact of haemophilia justifies physiotherapy throughout life. Recently the Dutch He...
A decision-analysis model was constructed to assess total direct health care costs of four current f...
The aim of this study was to assess the incremental cost effectiveness of on-demand versus prophylac...
Background Haemophilia is a rare hereditary haemorrhagic disease that requires regular intravenous i...
Objective: Hemophilia A is the second most common bleeding disorder causing patients to have lifelon...
Haemophilia A is a hereditary bleeding disorder, which has been considered rare and chronic. The bur...
Background : Haemophilia is a rare hereditary haemorrhagic disease requiring regular intravenous inj...
Summary. The interest in economic evaluation of alternative strategies for haemophilia treatment has...
Introduction and Objectives: Haemophilia is a rare hereditary haemorrhagic disease that requires reg...
Inhibitors in patients with hemophilia are a rare complication of a rare disease causing pain and di...
Inhibitors in patients with hemophilia are a rare complication of a rare disease causing pain and di...
Objectives. Haemophilia A is a congenital disorder of coagulation that mainly affects males and caus...
A number of studies examining the cost effectiveness of haemophilia prophylaxis have been published,...
The aim of the present study was to calculate the cost-effectiveness of on-demand and prophylactic t...
INTRODUCTION: Musculoskeletal impact of haemophilia justifies physiotherapy throughout life. Recentl...
Musculoskeletal impact of haemophilia justifies physiotherapy throughout life. Recently the Dutch He...
A decision-analysis model was constructed to assess total direct health care costs of four current f...
The aim of this study was to assess the incremental cost effectiveness of on-demand versus prophylac...
Background Haemophilia is a rare hereditary haemorrhagic disease that requires regular intravenous i...
Objective: Hemophilia A is the second most common bleeding disorder causing patients to have lifelon...
Haemophilia A is a hereditary bleeding disorder, which has been considered rare and chronic. The bur...
Background : Haemophilia is a rare hereditary haemorrhagic disease requiring regular intravenous inj...
Summary. The interest in economic evaluation of alternative strategies for haemophilia treatment has...
Introduction and Objectives: Haemophilia is a rare hereditary haemorrhagic disease that requires reg...
Inhibitors in patients with hemophilia are a rare complication of a rare disease causing pain and di...
Inhibitors in patients with hemophilia are a rare complication of a rare disease causing pain and di...
Objectives. Haemophilia A is a congenital disorder of coagulation that mainly affects males and caus...
A number of studies examining the cost effectiveness of haemophilia prophylaxis have been published,...
The aim of the present study was to calculate the cost-effectiveness of on-demand and prophylactic t...
INTRODUCTION: Musculoskeletal impact of haemophilia justifies physiotherapy throughout life. Recentl...
Musculoskeletal impact of haemophilia justifies physiotherapy throughout life. Recently the Dutch He...
A decision-analysis model was constructed to assess total direct health care costs of four current f...
The aim of this study was to assess the incremental cost effectiveness of on-demand versus prophylac...